一类人口发展方程解的存在性和收敛性的研究

用线性算子的理论将人口发展的偏微分方程模型转化为抽象的Cauchy问题,并用泛函分析中的C0半群理论来研究该系统解的存在性和收敛性.     

硬头黄竹地上生物量分配特征及模型构建

[目的]探究硬头黄竹不同龄级、径级地上生物量分配特征,建立全竹龄和不同竹龄地上单株及各器官生物量模型,准确估算硬头黄竹的林分生物量.[方法]选取了硬头黄竹全径级(1.0～7.0 cm)分布的1、2、3年生硬头黄竹各50株,测定各器官和总生物量.采用11种常用生物量模型,分别对硬头黄竹全竹龄和不同竹龄地上单株和各器官生物...     

嵌入式系统中USB Host功能的开发

采用自下向上的设计流程,在没有嵌入式操作系统支持的条件下,自主设计和实现了嵌入式USB Host功能．以ISP1362驱动USB海量存储类设备为例,描述了嵌入式USB Host系统的框架结构和底层驱动的设计方法．实验结果表明,遵从海量存储类子协议的USB设备,都能够被系统驱动,而且数据传输速度优于PC机驱动方式．     

基于主动学习的资源优化分配方案研究

从实际应用的角度阐述分析了主动学习算法在资源优化分配中的应用问题,首先分析了主动学习的发展问题,并给出了主动学习的数学描述,在此基础上,重点以学生分班为例阐述了主动学习算法的应用问题。     

基于类别不平衡的企业信用风险违约测度探索 ——以制造业上市公司为例

针对所获取的类别不平衡的深沪A股制造业上市公司财务数据,为了预测制造业上市公司信用违约情况,提出基于欠采样改进的Lasso-Logistic模型;首先通过计算WOE和IV值,剔除风险识别能力和稳定性较差的变量,接着从"数据"层面对现有的Lasso-Logistic模型进行批量欠采样处理,最后结合"算法"层面对Lasso...     

Diversity in enoyl-acyl carrier protein reductases

The enoyl-acyl carrier protein reductase (ENR) is the last enzyme in the fatty acid elongation cycle. Unlike most enzymes in this essential pathway, ENR displays an unusual diversity among organisms. The growing interest in ENRs is mainly due to the fact that a variety of both synthetic and natural antibacterial compounds are shown to specifically target their activity. The primary anti-tuberculosis drug, isoniazid, and the broadly used antibacterial compound, triclosan, both target this enzyme. In this review, we discuss the diversity of ENRs, and their inhibitors in the light of current research progress. Received 3 November 2008; received after revision 5 December 2008; accepted 8 December 2008     

Sugar-mimicking glycosidase inhibitors: bioactivity and application

A large number of compounds mimicking the structures of monosaccharides or oligosaccharides have been discovered from natural sources. Such sugar mimics inhibit carbohydrate-degrading enzymes because of a structural resemblance to the sugar moiety of the natural substrate. Carbohydrate-degrading enzymes are involved in a wide range of important biological processes, such as intestinal digestion, posttranslational processing of the sugar chain of glycoproteins, their quality control mechanisms, lysosomal catabolism of glycoconjugates, and some viral infections. It has now been realized that inhibitors of the enzymes have enormous therapeutic potential in diabetes and lysosomal storage disorders. In this review, the general bioactivity, current applications, and the prospects for new therapeutic applications are described. Received 27 August 2008; received after revision 08 November 2008; accepted 03 December 2008     

Direct inhibition of phospholipid scrambling activity in erythrocytes by potassium ions

The exposure of phosphatidylserine (PS) at the cell surface plays a critical role in blood coagulation and serves as a macrophage recognition moiety for the engulfment of apoptotic cells. Previous observations have shown that a high extracellular [K⁺] and selective K⁺ channel blockers inhibit PS exposure in platelets and erythrocytes. Here we show that the rate of PS exposure in erythrocytes decreases by ~50% when the intracellular [K⁺] increases from 0 to physiological concentrations. Using resealed erythrocyte membranes, we further show that lipid scrambling is inducible by raising the intracellular [Ca²⁺] and that K⁺ ions have a direct inhibitory effect on this process. Lipid scrambling in resealed ghosts occurs in the absence of cell shrinkage and microvesicle formation, processes that are generally attributed to Ca²⁺-induced lipid scrambling in intact erythrocytes. Thus, opening of Ca²⁺-sensitive K⁺ channels causes loss of intracellular K⁺ that results in reduced intrinsic inhibitory effect of these ions on scramblase activity. Received 11 September 2008; received after revision 17 October 2008; accepted 27 October 2008     

PPAR γ partial agonist, KR-62776, inhibits adipocyte differentiation via activation of ERK

Indenone KR-62776 acts as an agonist of PPARγ without inducing obesity in animal models and cells. X-ray crystallography reveals that the indenone occupies the binding pocket in a different manner than rosiglitazone. 2-Dimensional gel-electrophoresis showed that the expression of 42 proteins was altered more than 2.0-fold between KR-62776- or rosiglitazone-treated adipocyte cells and control cells. Rosiglitazone down-regulated the expression of ERK1/2 and suppressed the phosphorylation of ERK1/2 in these cells. However, the expression of ERK1/2 was up-regulated in KR-62776-treated cells. Phosphorylated ERK1/2, activated by indenone, affects the localization of PPARγ, suggesting a mechanism for indenone-inhibition of adipogenesis in 3T3-L1 preadipocyte cells. The preadipocyte cells are treated with ERK1/2 inhibitor PD98059, a large amount of the cells are converted to adipocyte cells. These results support the conclusion that the localization of PPARγ is one of the key factors explaining the biological responses of the ligands. Received 04 March 2009; received after revision 13 March 2009; accepted 17 March 2009